SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (104)6/16/1998 8:27:00 PM
From: scaram(o)uche  Read Replies (1) of 626
 
TD:

I won't bet on any anti-id vaccine until a company describes past attempts to induce effective responses and then explains why their antibody is different. Given Dr. Snodgrass' background, he should be able to tackle this within minutes of being asked.

Again, I'm not saying that it can't work. I think that it would take an exceptional antibody, with binding strongly determined by a a small portion of the CDR and characterized by strong ionic interaction. And, that's for an antigen like a pathogen. I just don't understand why anyone expects high affinity antibodies against self antigens. Would love to be wrong, for the stock and for the patients.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext